Top

Published in:

01-05-2014 | IMMUNOLOGY AT STANFORD UNIVERSITY

ImmPort: disseminating data to the public for the future of immunology

Authors: Sanchita Bhattacharya, Sandra Andorf, Linda Gomes, Patrick Dunn, Henry Schaefer, Joan Pontius, Patty Berger, Vince Desborough, Tom Smith, John Campbell, Elizabeth Thomson, Ruth Monteiro, Patricia Guimaraes, Bryan Walters, Jeff Wiser, Atul J. Butte

Published in: Immunologic Research | Issue 2-3/2014

Abstract

The immunology database and analysis portal (ImmPort) system is the archival repository and dissemination vehicle for clinical and molecular datasets created by research consortia funded by the National Institute of Allergy and Infectious Diseases Division of Allergy, Immunology, and Transplantation. With nearly 100 datasets now publicly available and hundreds of downloads per month, ImmPort is an important source for raw data and protocols from clinical trials, mechanistic studies, and novel methods for cellular and molecular measurements. To facilitate data transfer, templates for data representation and standard operating procedures have also been created and are also publicly available. ImmPort facilitates transparency and reproducibility in immunology research, serves as an important resource for education, and enables newly generated hypotheses and data-driven science.

Qian Y, Wei C, Eun-Hyung Lee F, Campbell J, Halliley J, Lee JA, et al. Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data. Cytometry B Clin Cytom. 2010;78(Suppl 1):S69–82. doi:10.1002/cyto.b.20554.PubMedCentralCrossRefPubMed

Li L, Khatri P, Sigdel TK, Tran T, Ying L, Vitalone MJ, et al. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant. 2012;12(10):2710–8. doi:10.1111/j.1600-6143.2012.04253.x.PubMedCentralCrossRefPubMed

Benfield MR, Bartosh S, Ikle D, Warshaw B, Bridges N, Morrison Y, et al. A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation. Am J Transplant. 2010;10(1):81–8. doi:10.1111/j.1600-6143.2009.02767.x.CrossRefPubMed

De Serres SA, Mfarrej BG, Magee CN, Benitez F, Ashoor I, Sayegh MH, et al. Immune profile of pediatric renal transplant recipients following alemtuzumab induction. J Am Soc Nephrol. 2012;23(1):174–82. doi:10.1681/ASN.2011040360.PubMedCentralCrossRefPubMed

Harmon W, Meyers K, Ingelfinger J, McDonald R, McIntosh M, Ho M, et al. Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. J Am Soc Nephrol. 2006;17(6):1735–45. doi:10.1681/ASN.2006010049.CrossRefPubMed

Hoerning A, Koss K, Datta D, Boneschansker L, Jones CN, Wong IY, et al. Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3. Eur J Immunol. 2011;41(8):2291–302. doi:10.1002/eji.201041095.PubMedCentralCrossRefPubMed

McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, et al. Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant. 2008;8(5):984–9. doi:10.1111/j.1600-6143.2008.02167.x.CrossRefPubMed

Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol. 2006;117(1):134–40. doi:10.1016/j.jaci.2005.09.036.CrossRefPubMed

Klunker S, Saggar LR, Seyfert-Margolis V, Asare AL, Casale TB, Durham SR, et al. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol. 2007;120(3):688–95. doi:10.1016/j.jaci.2007.05.034.CrossRefPubMed

10.

Newell EW, Sigel N, Bendall SC, Nolan GP, Davis MM. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8(+) T cell phenotypes (vol 36, pg 142, 2012). Immunity. 2013;38(1):198–9. doi:10.1016/j.immuni.2012.12.002.CrossRef

11.

Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med. 2013;5(208):208ra145. doi:10.1126/scitranslmed.3006702.PubMedCentralCrossRefPubMed

12.

Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221–32. doi:10.1056/NEJMoa0909905.PubMedCentralCrossRefPubMed

13.

Holdren JP. Increasing access to the results of federally funded scientific research. Executive Office of the President, Washington, DC. 2013. http://www.whitehouse.gov/sites/default/files/microsites/ostp/ostp_public_access_memo_2013.pdf. Accessed Feb 22, 2013.

14.

Shen-Orr SS, Goldberger O, Garten Y, Rosenberg-Hasson Y, Lovelace PA, Hirschberg DL et al. Towards a cytokine-cell interaction knowledgebase of the adaptive immune system. Pac Symp Biocomput. 2009. http://www.ncbi.nlm.nih.gov/pubmed/?term=19209721.

15.

Piwowar HA, Vision TJ. Data reuse and the open data citation advantage. Peer J. 2013;1:e175. doi:10.7717/peerj.175.PubMedCentralCrossRefPubMed

16.

Begley CG, Ellis LM. Drug development: raise standards for preclinical cancer research. Nature. 2012;483(7391):531–3. doi:10.1038/483531a.CrossRefPubMed

17.

Ioannidis JP, Allison DB, Ball CA, Coulibaly I, Cui X, Culhane AC, et al. Repeatability of published microarray gene expression analyses. Nat Genet. 2009;41(2):149–55. doi:10.1038/ng.295.CrossRefPubMed

18.

Micheel C, Nass SJ, Omenn GS, Institute of Medicine (U.S.). Committee on the review of omics-based tests for predicting patient outcomes in clinical trials. Evolution of translational omics: lessons learned and the path forward. Washington, D.C.: National Academies Press; 2012.

19.

Chen R, Sigdel TK, Li L, Kambham N, Dudley JT, Hsieh SC et al. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput Biol. 2010;6(9). doi:10.1371/journal.pcbi.1000940.

20.

Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, Irie J, et al. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A. 2012;109(18):7049–54. doi:10.1073/pnas.1114513109.PubMedCentralCrossRefPubMed

21.

Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013;45(9):970–6. doi:10.1038/ng.2702.PubMedCentralCrossRefPubMed

22.

Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A, et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med. 2011;3(96):96ra77. doi:10.1126/scitranslmed.3001318.PubMedCentralCrossRefPubMed

23.

Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med. 2011;3(96):96–976. doi:10.1126/scitranslmed.3002648.CrossRef

Title: ImmPort: disseminating data to the public for the future of immunology
Authors: Sanchita Bhattacharya
Sandra Andorf
Linda Gomes
Patrick Dunn
Henry Schaefer
Joan Pontius
Patty Berger
Vince Desborough
Tom Smith
John Campbell
Elizabeth Thomson
Ruth Monteiro
Patricia Guimaraes
Bryan Walters
Jeff Wiser
Atul J. Butte
Publication date: 01-05-2014
Publisher: Springer US
Published in: Immunologic Research / Issue 2-3/2014
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-014-8516-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

ImmPort: disseminating data to the public for the future of immunology

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2-3/2014

Path to clinical transplantation tolerance and prevention of graft-versus-host disease

Leukotrienes in pulmonary arterial hypertension

Effects of serum and plasma matrices on multiplex immunoassays

Function of the tetraspanin molecule CD81 in B and T cells

Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis

A killer choice for cancer immunotherapy